Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 22

Publication Record

Connections

Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.
Neumann W, Crews BC, Marnett LJ, Hey-Hawkins E
(2014) ChemMedChem 9: 1150-3
MeSH Terms: Antineoplastic Agents, Cell Line, Tumor, Cell Survival, Cisplatin, Cyclooxygenase Inhibitors, Drug Design, Drug Resistance, Neoplasm, HCT116 Cells, Humans, Neoplasms, Organoplatinum Compounds
Added June 1, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Beyond exon 2--the developing story of RAS mutations in colorectal cancer.
Berlin J
(2013) N Engl J Med 369: 1059-60
MeSH Terms: Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms, ErbB Receptors, Fluorouracil, Genes, ras, Humans, Leucovorin, Organoplatinum Compounds, Panitumumab, Proto-Oncogene Proteins, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras), ras Proteins
Added March 20, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Aflibercept.
Ciombor KK, Berlin J, Chan E
(2013) Clin Cancer Res 19: 1920-5
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Colorectal Neoplasms, Disease-Free Survival, Fluorouracil, Humans, Irinotecan, Leucovorin, Neoplasm Metastasis, Organoplatinum Compounds, Oxaliplatin, Placenta Growth Factor, Pregnancy Proteins, Protein Binding, Randomized Controlled Trials as Topic, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Treatment Outcome, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor B
Added September 10, 2013
0 Communities
4 Members
0 Resources
22 MeSH Terms
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.
Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, Mulcahy MF, Zalupski MM, Mackey HM, Yauch RL, Graham RA, Bray GL, Low JA
(2013) Clin Cancer Res 19: 258-67
MeSH Terms: Adult, Aged, Aged, 80 and over, Anilides, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Camptothecin, Colorectal Neoplasms, Female, Fluorouracil, Humans, Leucovorin, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Metastasis, Organoplatinum Compounds, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Pyridines, Treatment Outcome, ras Proteins
Added March 7, 2014
0 Communities
1 Members
0 Resources
23 MeSH Terms
Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.
Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, Samuel S, Liebler DC, Ellis LM
(2011) Br J Cancer 105: 1759-67
MeSH Terms: Animals, Antineoplastic Agents, Bystander Effect, Cell Line, Tumor, Cell Survival, Colorectal Neoplasms, Culture Media, Drug Resistance, Neoplasm, ErbB Receptors, HCT116 Cells, HT29 Cells, Humans, Intercellular Signaling Peptides and Proteins, MAP Kinase Kinase 1, Male, Mass Spectrometry, Mice, Mice, Nude, Microarray Analysis, Neoplastic Stem Cells, Organoplatinum Compounds, Oxaliplatin, Phosphorylation, Progranulins, Proto-Oncogene Proteins c-akt, Signal Transduction, Up-Regulation
Added March 20, 2014
0 Communities
1 Members
0 Resources
27 MeSH Terms
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.
Wheeler HE, Gamazon ER, Stark AL, O'Donnell PH, Gorsic LK, Huang RS, Cox NJ, Dolan ME
(2013) Pharmacogenomics J 13: 35-43
MeSH Terms: Carboplatin, Cell Line, Cisplatin, Drug Resistance, Neoplasm, Follow-Up Studies, Genome-Wide Association Study, Humans, Neoplasm Proteins, Organoplatinum Compounds, Polymorphism, Single Nucleotide
Added February 22, 2016
0 Communities
2 Members
0 Resources
10 MeSH Terms
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.
Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH
(2012) Cancer 118: 1007-13
MeSH Terms: Adult, Aged, Antineoplastic Agents, Disease-Free Survival, Drug Therapy, Combination, Female, Glutamates, Guanine, Head and Neck Neoplasms, Humans, Induction Chemotherapy, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Staging, Organoplatinum Compounds, Outcome Assessment, Health Care, Oxaliplatin, Pemetrexed, Severity of Illness Index, Survival Rate, Treatment Outcome
Added March 5, 2014
0 Communities
2 Members
0 Resources
22 MeSH Terms
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
Merchan JR, Ferrell A, Macintyre J, Ciombor KK, Levi J, Ribeiro A, Sleeman D, Flores A, Lopes G, Rocha-Lima CM
(2012) Am J Clin Oncol 35: 446-50
MeSH Terms: Adenocarcinoma, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Pancreatic Ductal, Carcinoma, Squamous Cell, Cetuximab, Deoxycytidine, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Staging, Organoplatinum Compounds, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Treatment Outcome
Added September 10, 2013
0 Communities
2 Members
0 Resources
21 MeSH Terms
Update on new drugs in small cell lung cancer.
Horn L, Castellanos EL, Johnson DH
(2011) Expert Opin Investig Drugs 20: 441-5
MeSH Terms: Angiogenesis Inhibitors, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Clinical Trials as Topic, Drugs, Investigational, Enzyme Inhibitors, Humans, Lung Neoplasms, Nitrogen Mustard Compounds, Organoplatinum Compounds, Small Cell Lung Carcinoma
Added June 26, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, Alberts S, O'Dwyer P, Haller D, Catalano P, Cella D, Benson AB
(2009) J Clin Oncol 27: 3778-85
MeSH Terms: Adult, Aged, Antimetabolites, Antineoplastic, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine, Disease-Free Survival, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Kaplan-Meier Estimate, Male, Middle Aged, Organoplatinum Compounds, Oxaliplatin, Pancreatic Neoplasms, Treatment Outcome, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms